Singapore: US-based Targeted Medical Pharma has signed an exclusive product distribution agreement with J-Network, a California-based company that specializes in distributing cosmetic and healthcare goods exclusively in Japan.

The agreement grants J-Network an exclusive one-year renewable license for the marketing and sales of the company's proprietary product, designed to improve sleep and immune function, in Japan. Under the terms of the Agreement, Targeted Medical Pharma will develop new products specific for import into the Japanese market, and J-network is responsible for a guaranteed initial order of 360,000 capsules as well as maintaining annual minimum purchase orders of 1.4 million capsules for the first two years, and 2.1 million capsules thereafter.